http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2017002423-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b3127c0ebee3f865b211b019fac84286
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1bd69955f5284f588575c1b9a35eadb2
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-178
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
filingDate 2015-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_68f33a9c155aea9c03581af027ce729f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6c1af930b6dbfdce95a675e5b9bfbf37
publicationDate 2017-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2017002423-A1
titleOfInvention Microrna signature for predicting progression of barrett's esophagus
abstract Biomarkers, methods, assays, and kits are provided for predicting the progression of Barrett esophagus in a subject to esophageal cancer. The method can therefore also be used to select the appropriate treatment for a subject diagnosed with Barrett esophagus. Disclosed are methods for predicting the progression of Barrett esophagus in a subject to esophageal cancer. The method can therefore also be used to select the appropriate treatment for a subject diagnosed with Barrett esophagus. For example, the disclosed biomarkers, methods, assays, and kits can be used to predict the benefit of surgery, laser treatment, radiofrequency ablation, radiation therapy, chemotherapy, or any combination thereof for a subject diagnosed with Barrett esophagus based on whether they are predicted to progress to esophageal cancer.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020016437-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112609002-A
priorityDate 2014-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8415102-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014363469-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409068
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID503000
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399873
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID614630
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395944
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID712
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24293
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP36375
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135577896
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID58117
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ03181
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447566935
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425901710
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394110
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID150009356
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID56998
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP06873
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID136187588
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP22629
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415728619
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35396
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID67087
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID171548

Total number of triples: 44.